DOP058 Pharmacokinetic and pharmacodynamic relationship and immunogenicity of vedolizumab in adults with inflammatory bowel disease: Additional results from the GEMINI 1 and 2 studiesM. Rosario, Irving H. Fox, Catherine Milch et al.|Journal of Crohn s and Colitis|2014Cited by 24